Immunocore Holdings plc

Commercial-stage TCR-bispecific biotech with KIMMTRAK and multiple late-stage melanoma programs.

Back to company catalog

Oncology, infectious & autoimmune disease · TCR bispecific ImmTAX therapies · Commercial + Phase 3

Compare report options